Meike E W Logtenberg

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Intellectual Disability

Dendritic Cells

Tyrosine Kinase

Cell Cycle Arrest

Top Venues

Nature medicine

Scientific reports

Journal of immunology (Baltimore, Md. : 1950)

Antoni van Leeuwenhoek Nederlands Kanker Instituut

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Antoni van Leeuwenhoek Nederlands Kanker Instituut Oct 05 2015

Netherlands

PhD :: Molecular Oncology and Immunology

Publications

Connor A Richterich, Meike E W Logtenberg, Marco J H Jansen, Mireille Toebes, Kaspar Bresser, Anne Borst, Anouk P Jurgens, Jeanette H W Leusen, Ton N M Schumacher
ITPK1 Sensitizes Tumor Cells to IgA-dependent Neutrophil Killing In Vivo. Journal of immunology (Baltimore, Md. : 1950) (2024)
Kaspar Bresser, Meike E W Logtenberg, Mireille Toebes, Natalie Proost, Justin Sprengers, Bjorn Siteur, Manon Boeije, Lona J Kroese, Ton N M Schumacher
QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment. Oncoimmunology 11 (1) (2022)
Victor A Negri, Meike E W Logtenberg, Lisa M Renz, Bénédicte Oules, Gernot Walko, Fiona M Watt
Delta-like 1-mediated cis-inhibition of Jagged1/2 signalling inhibits differentiation of human epidermal cells in culture. Scientific reports 9 (1) (2019)
Meike E W Logtenberg, J H Marco Jansen, Matthijs Raaben, Mireille Toebes, Katka Franke, Arianne M Brandsma, Hanke L Matlung, Astrid Fauster, Raquel Gomez-Eerland, Noor A M Bakker, Simone van der Schot, Koen A Marijt, Martijn Verdoes, John B A G Haanen, Joost H van den Berg, Jacques J C Neefjes, Timo K van den Berg, Thijn R Brummelkamp, Jeanette H W Leusen, Ferenc A Scheeren, Ton N M Schumacher
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy. Nature medicine 25 (4) (2019)